Dr. Alizadeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Stanford Comprehensive Cancer Center
875 Blake Wilbur Drive, MailCode MC-6560
Stanford, CA 94305Phone+1 650-498-6000Fax+1 650-724-1231
Summary
- Ash Alizadeh, MD, is an oncologist based in Stanford, CA. He holds a fellowship in Hematology and completed his residency in Internal Medicine, both at Stanford Health Care-Sponsored Stanford University. Dr. Alizadeh is currently a Professor at Stanford University School of Medicine and has experience in various areas such as medical oncology, hodgkin lymphoma, non-hodgkin lymphoma, immunotherapy, and hematologic oncology. His research has been widely recognized, with publications in prestigious journals like NEJM, Cell, JCO, Blood, JAMA, JAMA Oncology, Nature, and Clinical Cancer Research. He is especially known for his contributions to the advancement of immune checkpoint inhibition therapy. He was awarded the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation in 2011-2013.
Clinical Expertise
- Lymphoma, Genes, Computational biology, Immunotherapy, Human Genome, Clinical Trials as Topic, Hematology, General medical oncology, Hematologic oncology, Leukemia, Multiple myeloma, Spinal lymphoma, Oropharyngeal lymphoma, Non-Hodgkin lymphoma, Angiocentric lymphoma, Medical oncology, Ophthalmic oncology
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2006 - 2010- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2004 - 2006
Stanford University School of MedicineClass of 2003
Work Experience
Stanford University School of MedicineAssociate Professor · April 2018 - Current- Stanford University School of MedicineAssistant Professor · January 2011 - Current
Certifications & Licensure
CA State Medical License 2005 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- 4826 citationsRobust enumeration of cell subsets from tissue expression profilesAaron M. Newman, Chih Long Liu, Michael R. Green, Andrew J. Gentles, Weiguo Feng
Nature Methods. 2015-05-01 - 811 citationsAnti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin LymphomaMark P. Chao, Ash A. Alizadeh, Chad Tang, June Helen Myklebust, Bindu Varghese
Cell. 2010-09-03 - 77 citationsLarge-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human AgingChan C. Whiting, Janet C. Siebert, Aaron M. Newman, Hongwu Du, Ash A. Alizadeh
Plos One. 2015-07-21
Abstracts/Posters
- An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell LymphomaAsh A Alizadeh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid MalignanciesArash A. Alizadeh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin LymphomaAsh A Alizadeh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
